Wednesday, March 27, 2024
Essential Pharma, a global specialty pharmaceutical group dedicated to ensuring sustainable access to essential pharmaceutical products in key therapeutic areas, has announced the signing of a Distribution Agreement with AcedrA BioPharmaceuticals, a prominent company based in Saudi Arabia operating across the Middle East and North Africa (MENA) region. This strategic collaboration aims to meet both commercial and medical needs by enabling AcedrA to register, promote, and commercialize a portfolio of 36 Essential Medicines across various therapeutic areas in 12 countries within the MENA region.
Specializing in providing access to low-volume, clinically significant medicines for chronic and acute conditions, Essential Pharma is a leader in acquiring, integrating, and safeguarding medicines that are at risk of shortages or discontinuation. The company works collaboratively with partners globally to maintain the highest standards in pharmaceutical manufacturing.
Emma Johnson, CEO of Essential Pharma, expressed enthusiasm about the partnership, stating, "We are excited to announce our collaboration with AcedrA BioPharmaceuticals as we continue our mission to ensure sustainable access to vital medicines. This alliance represents a significant stride in addressing medical needs in the Middle East and North Africa, ensuring patients have access to high-quality treatments across diverse therapeutic areas. Together, we are dedicated to enhancing patient outcomes and positively impacting healthcare systems worldwide."
Under the agreement, AcedrA will undertake the responsibility of registering, promoting, and commercializing 36 specialty essential medicines spanning therapeutic areas such as Ophthalmology, Gastroenterology, Cardiovascular, Dermatology, Endocrinology, Neurology, Gynecology, Infectious Diseases, Respiratory, and Rheumatology in the MENA region.
Dr. Hosni STA, the Chief Executive Officer of AcedrA, emphasized the company's commitment to patient-centered care, stating, "AcedrA is dedicated to serving patient and scientific communities in the MENA region where significant needs exist. We believe that the synergy between AcedrA and Essential Pharma in ensuring sustainable access to essential medicines will greatly benefit patients and healthcare providers facing limited options. We look forward to partnering strategically with Essential Pharma to enhance healthcare access in the region."
The distribution will encompass products in Saudi Arabia, United Arab Emirates, Qatar, Bahrain, Kuwait, Oman, Jordan, Lebanon, Libya, Tunisia, Algeria, and Morocco.
Source: globenewswire.com
